This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Liquid Biopsy

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Liquid Biopsy Means

A liquid biopsy is a laboratory test that examines a sample of blood or other body fluids to find cancer cells or small pieces of DNA released by tumor cells. These DNA fragments, often called circulating tumor DNA (ctDNA), carry genetic information from the cancer. Because they float freely in the bloodstream, doctors can detect and analyze them through a simple blood test. This approach offers a less invasive way to learn about the tumor compared to traditional biopsies, which require removing tissue directly from the tumor.

Why Liquid Biopsy Can Matter in Cancer Care

Liquid biopsies provide real-time information about the cancer’s genetic makeup and how it changes over time. This can help doctors understand the stage of tumor progression, how well treatments are working, and the risk that cancer may spread. Unlike tissue biopsies, which give a snapshot of the tumor at one moment, liquid biopsies can be done repeatedly to track changes in the cancer’s DNA. This helps guide treatment decisions and monitor for cancer recurrence or resistance to therapy.

What Patients Might See or Hear About Liquid Biopsy

If your care team recommends a liquid biopsy, you may hear terms like circulating tumor DNA (ctDNA) or circulating tumor cells (CTCs). These tests might be mentioned in your medical reports, treatment plans, or clinical trial information. It’s important to ask your doctor how the results relate to your specific cancer and treatment options. Liquid biopsy results are one part of a larger picture that includes imaging, physical exams, and other lab tests.

What Liquid Biopsy Does Not Automatically Mean

Finding tumor DNA in the blood does not always mean the cancer is growing or spreading. Not all cancers release enough DNA to be detected, and a negative test does not rule out cancer. Liquid biopsy results need careful interpretation by your healthcare team and should not be used alone to make decisions about diagnosis or treatment.

How Doctors Use Liquid Biopsy in Care

Doctors use liquid biopsy to help diagnose certain cancers, select targeted treatments based on genetic changes, monitor how well treatment is working, and detect if cancer has returned after therapy. Because it is less invasive than tissue biopsy, it can be repeated multiple times to track the cancer’s progress. In some cases, liquid biopsy can detect changes months or years before imaging tests show them.

Common Questions to Ask Your Care Team

If a liquid biopsy is part of your care, you might ask, "What does this test tell us about my cancer?" or "How will the results affect my treatment plan?" Understanding why the test is done and what the results mean can help you feel more informed and involved in your care.

How to Read Liquid Biopsy Results in Context

Liquid biopsy is a powerful tool but is usually combined with other tests and clinical information. It is best to view the results as part of a bigger picture rather than a standalone diagnosis or treatment guide. Always discuss your results with your healthcare team to understand what they mean for your individual situation.

Safety and Next Steps

This information is educational and does not replace medical advice. If you see the term liquid biopsy in your medical records or hear it from your care team, the safest next step is to ask how it applies to your care. Your healthcare providers can explain what the test results mean for you and help guide your treatment decisions.

Sources

Public source information used for this glossary entry includes: